Home › NCT07139769
Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer * Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer * Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer * English-speaking * Aged over 18 years Exclusion Criteria: -Active symptoms of psychosis or suicidal ideation that would preclude safe participation
About the study
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
What is being tested
- Psychosocial Intervention for Parental Caregivers of AYA with Cancer (behavioral)
Sponsor: Zeba Ahmad, Ph.D. · Participants: 48 · Started: 2026-09
Contact the study team
- Zeba N Ahmad, Ph.D. · Phone: 16177241586
- Katana Corning, B.A. · Phone: 6177247593
Official record on ClinicalTrials.gov — NCT07139769
Locations in the U.S.
| Massachusetts | Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.